CD19+ Malignancies: Relapse Post-allogeneic Transplant
1 clinical trials · Condition
◉ Watch CD19+ Malignancies: Relapse Post-allogeneic Transplant
| Record | Firm | Date |
|---|---|---|
| CAR19 Donor Lymphocytes for Relapsed CD19+ Malignancies Following Allogeneic Transplantation (NCT02893189) | University College, London | 2017-04-27 |
Track CD19+ Malignancies: Relapse Post-allogeneic Transplant automatically
Every clearance here is in the API, with alerts when new ones post.